164 related articles for article (PubMed ID: 16219656)
1. Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration.
Strauss MH; Lonn EM; Verma S
Eur Heart J; 2005 Nov; 26(22):2351-3. PubMed ID: 16219656
[No Abstract] [Full Text] [Related]
2. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
5. ACE inhibitors and ARBs: antihypertensive medications in CKD.
Szromba C
Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
[No Abstract] [Full Text] [Related]
6. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Onuigbo MA
Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
[No Abstract] [Full Text] [Related]
7. Blood pressure drugs compared. ACE inhibitors beat ARBs hands-down for survival benefit.
Harv Heart Lett; 2012 Jun; 22(10):5. PubMed ID: 22764400
[No Abstract] [Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
9. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
Baer JT; Sauer WH; Berlin JA; Kimmel SE
Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
Weber MA; Giles TD
Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
[TBL] [Abstract][Full Text] [Related]
11. AT1-receptor blockers and ACE inhibitors: alternatives or partners?
Ruilope LM
Int J Clin Pract Suppl; 2000 Aug; (111):20-4. PubMed ID: 15977403
[No Abstract] [Full Text] [Related]
12. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471
[No Abstract] [Full Text] [Related]
13. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
[TBL] [Abstract][Full Text] [Related]
14. Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.
Hao G; Wang Z; Guo R; Chen Z; Wang X; Zhang L; Li W
BMC Cardiovasc Disord; 2014 Oct; 14():148. PubMed ID: 25344747
[TBL] [Abstract][Full Text] [Related]
15. [Not all antihypertensive agents protect equally well].
MMW Fortschr Med; 2006 Aug; 148(33-34):52. PubMed ID: 16981390
[No Abstract] [Full Text] [Related]
16. Blood pressure reduction is not the only determinant of outcome.
Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
[No Abstract] [Full Text] [Related]
17. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
18. More about the "ARB MI paradox".
Hall AS; Strauss MH
Heart; 2007 Sep; 93(9):1011-4. PubMed ID: 17699164
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
20. Revisiting evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration: fractional polynomials meta-regression of blood pressure reduction by angiotensin-converting enzyme inhibitors on stroke risk.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
Int J Cardiol; 2013 Oct; 168(4):4590-2. PubMed ID: 23890905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
